OAC Urges Cigna to Reconsider Decision on GLP-1 Medication Coverage for Weight Management
The Obesity Action Coalition (OAC) is urging health insurance provider Cigna to reverse its decision to stop covering GLP-1 medications used for weight management. In June, Cigna informed over 50,000 U.S. employees that the company would no longer cover these drugs under their health plans as of July 1st. The move has sparked significant backlash from affected workers, with nearly 600 signing a petition to reinstate coverage. Cigna defended its decision in a statement to Bloomberg Businessweek, citing research and input from internal leaders including clinical experts. It also highlighted alternative resources like health coaching for weight management support. However, employees have reported significant financial burdens due to the change—some now paying up to $300 per month out of pocket compared to previous costs as low as $25. OAC CEO Joe Nadglowski emphasized that obesity is a chronic disease requiring long-term treatment and urged Cigna to reconsider its policy. He argued that while lifestyle support can be helpful, it should not replace medically prescribed treatments for employees living with the condition.
Topics: employee benefits GLP-1 medications health insurance obesity treatment